Solid Tumor Malignancies Completed Phase 1 Trials for Docetaxel (DB01248)

Also known as: Solid Tumor Malignancy

IndicationStatusPhase
DBCOND0032723 (Solid Tumor Malignancies)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01183364A Dose Escalation Study of STA-9090 and Docetaxel in Patients With Solid TumorsTreatment